Syntophyllin (Aminophylline) is commonly used for managing symptoms associated with lung diseases. It is applied across domains where additional symptomatic support is needed for patients experiencing conditions characterized by periods of heightened symptoms. This medication may assist with managing symptoms that cluster in chronic conditions, including asthma, chronic bronchitis, and emphysema.

Symptomatic Support for Breathing Distress

Syntophyllin is primarily used to address symptomatic discomfort associated with Chronic Obstructive Pulmonary Diseases (COPD). It is applied in situations involving reversible airway obstruction to provide support that helps ease the overall symptom load from manifestations like wheezing and persistent chest tightness, which helps improve day-to-day comfort during symptomatic periods. Furthermore, it plays a role in managing symptoms that appear suddenly during acute exacerbations, providing short-term symptomatic assistance with pronounced symptoms such as shortness of breath and difficulty breathing.

“It is commonly used when symptoms intensify and supportive relief is needed.”

It is also relevant in specific patient groups for managing temporary functional strain, offering specialized support for breathing irregularities, such as apnea of prematurity in premature infants, which assists with maintaining functional stability.

---

Quick Fact: Focus on Airway Constriction Symptoms The medication is commonly used to help with symptomatic manifestations linked to airway muscle constriction and functional strain on the respiratory system.

Regulatory References

1. NIH MedlinePlus Drug Information overview

Who can and cannot use Syntophyllin?

This section explains the population eligibility and restrictions for Syntophyllin (Aminophylline) as documented in official government regulatory information.

Absolute Contraindications

Syntophyllin is strictly contraindicated and must not be used by individuals with a known hypersensitivity or allergy to the active component Aminophylline (Theophylline) or the excipient Ethylenediamine. Regional regulations may also cite contraindications for patients with certain specific conditions like Active Peptic Ulcer Disease or underlying Seizure Disorders.

Age-Related and Conditional Eligibility

Population Group	Eligibility Status (Regulatory Basis)
Children under 1 year	Conditional Use. Requires particular caution and frequent monitoring due to immature drug clearance pathways. Use in infants under six months is not recommended in certain regions.
Elderly Patients (typically over 60)	Conditional Use. Increased risk of toxicity due to reduced clearance, necessitating special consideration.
Patients with Certain Conditions	Conditional Use. Extreme caution is required for patients with Congestive Heart Failure, Liver Disease (e.g., cirrhosis), Severe Infection, or Hypothyroidism. These conditions significantly reduce Theophylline clearance.
Pregnancy and Lactation	Conditional Use. Should be used only if clearly needed. Theophylline is excreted into breast milk and may cause irritability in nursing infants, requiring caution and monitoring.

Interactions with other medicines and products

Syntophyllin (Aminophylline) interactions are primarily defined by its active component, Theophylline, which is highly sensitive to co-administered substances.

Regulatory documentation outlines significant pharmacokinetic and pharmacodynamic interactions.

---

Formal Restrictions and Major Interactions

Official labeling classifies co-administration with Riociguat and Viloxazine as not recommended. The combination of Ephedrine in children is also documented as a contraindication. Furthermore, co-administration with other Xanthine Derivatives is advised against due to the risk of additive toxic effects.

---

Pharmacokinetic Alterations

Many substances formally alter Theophylline's plasma concentration by modifying its hepatic clearance. Inhibitors like Ciprofloxacin, Fluvoxamine, and Cimetidine significantly reduce clearance, increasing exposure and concentration. Conversely, inducers such as Rifampicin and Phenytoin increase clearance, resulting in reduced Theophylline exposure. This is a critical factor noted in regulatory documents.

---

Pharmacodynamic and Lifestyle Factors

Beta-Adrenergic Agonists may potentiate the risk of hypokalaemia due to additive effects. The label also documents that Tobacco Smoking and the herbal product St. John's Wort formally increase clearance. Timing rules require sustained-release tablets to be dosed consistently (with or without food). Caution is noted for populations with liver disease or those over 60, where reduced clearance is documented.

The mechanism of Syntophyllin (Theophylline) involves modulation of several distinct molecular pathways. Its primary action is a dual effect on cellular signaling: non-selective inhibition of Phosphodiesterase (PDE) enzymes (notably PDE3 and PDE4), which prevents the hydrolysis of the second messenger cyclic AMP (cAMP); and non-selective competitive antagonism at Adenosine Receptors (A1, A2A, etc.). The resulting elevation in cAMP and cGMP levels within bronchial cells leads to a decrease in intracellular Ca^2+ concentration, which produces a reduction of smooth muscle tone in the airways.

Beyond smooth muscle, the drug systemically influences the Ca^2+ kinetics in striated muscle, such as the diaphragm, promoting enhanced force generation that is associated with enhanced function of the respiratory mechanics. Furthermore, the drug acts on the nucleus to restore the function of Histone Deacetylase-2 ( HDAC2). Activating HDAC2 promotes the switching off of inflammatory genes, which results in the dampening of pro-inflammatory mediator production and influences cellular signaling stability.

Official Administration Guidelines

The usage of Syntophyllin (Aminophylline) is determined by its active ingredient, a methylxanthine derivative, and is governed by established instructions to ensure proper dosing. The medication is delivered via two primary official routes: Intravenous (IV) for acute, short-term needs and Oral tablets for ongoing maintenance.

Administration Component	Standard Administration Guidelines
Dosing Calculation	All doses are calculated based on Ideal Body Weight (IBW) to prevent excessive dosing.
Therapeutic Target	Dosage is individualized and adjusted to achieve a specific target serum concentration of theophylline, typically 10 to 15 mcg/mL.
IV Loading Dose	A dose of 5.7 to 6 mg/kg (Aminophylline) is administered over 20 to 30 minutes for patients not recently on theophylline products.
IV Administration Rate	The intravenous injection rate must not exceed 25 mg/minute.
Oral Tablet Handling	Sustained-release tablets must be swallowed whole and not crushed or chewed.
Population Adjustment	Dose reduction is required for older adults and patients with hepatic impairment.
Missed Dose Rule	If an oral dose is missed, skip it if it is almost time for the next dose; do not take a double dose.

For IV use, the solution must be diluted in a compatible intravenous fluid prior to infusion. The use of this drug is generally not recommended for children under 6 months of age. The administration process involves continuous dose titration against serum levels to maintain the narrow, defined therapeutic range.

Research Evidence / Overview of Studies for Syntophyllin

Evidence Structure for Acute Episodes of Breathing Difficulty (Exacerbations)

Syntophyllin was evaluated in research exploring acute episodes of breathing patterns, which are phases of heightened symptom activity associated with asthma and Chronic Obstructive Pulmonary Disease (COPD). Research in this area primarily involves short-term Clinical Trials and observational settings. These studies monitored outcomes capturing phases of heightened symptom activity, including patient reports of physical discomfort or objective measurements like lung function tests. Evidence remains limited; many of the existing trials featured modest sample sizes, and results were observed to show variation across different studies.

Evidence Structure for Managing Chronic Breathing Symptoms (Asthma, Bronchitis, Emphysema)

Research examined Syntophyllin's role in providing symptomatic support for conditions characterized by fluctuating or episodic manifestations. Studies explored patient-reported experiences, monitoring outcomes describing perceived discomfort (such as wheezing or chest tightness) and outcomes reflecting daily functioning. It is noted that much of this evidence is derived from older research, and information on long-term outcomes is not fully established.

Evidence Structure for Functional Stability in Premature Infants

Syntophyllin was observed in controlled studies, including Randomized Controlled Trials, specifically within neonatal care settings for conditions marked by functional limitations (apnea of prematurity). Researchers monitored changes measured during the study period, such as the frequency of breathing irregularities. Findings describe patterns observed in the studies related to maintaining or observing changes in stable breathing function in this specific patient group.

What Research Still Needs to Clarify (Uncertainty and Gaps)

The existing evidence base was studied for a limited range of scenarios, and evidence quality varies across studies due to factors like modest sample sizes and inconsistencies in how outcomes were tracked. Comparative evidence is lacking in certain areas against newer treatment modalities. This research provides context about what has been observed in group patterns, but findings describe group patterns, not personal outcomes.

Key Studies & References Aminophylline (Systemic) - Drug Information (Therapeutic Purpose and Indications)

Common questions about Syntophyllin (FAQ)

Q: What is the main function of the active ingredient in Syntophyllin?

The active ingredient, theophylline, is described in official regulatory documents as working in two main ways. It acts as a bronchodilator by relaxing the smooth muscles of the airways. Additionally, it is noted for suppressing the airway's response to stimuli, which may assist in maintaining airway patency.

Q: Is Syntophyllin a non-prescription medication?

According to the official product information and regulatory descriptions, Syntophyllin (Aminophylline/Theophylline) is available only with a prescription from a licensed healthcare provider.

Q: What is the official primary indication for Syntophyllin?

Official regulatory documents state that Syntophyllin is indicated for the treatment of symptoms associated with reversible bronchospasm. This includes conditions like bronchial asthma, chronic bronchitis, and emphysema.

Q: Why is continuous health monitoring sometimes recommended for patients using Syntophyllin?

Continuous monitoring is often recommended because the dosage is adjusted to maintain the drug’s concentration within a narrow therapeutic window. Official product information specifies this window is typically 10 to 15 mcg/mL. This monitoring is used to help manage the therapeutic benefit and the potential for adverse reactions.

Q: Is it medically acceptable to crush or divide Syntophyllin tablets?

Official guidance on administration states that extended-release or modified-release tablets is described as needing to be swallowed whole. They should not be crushed, broken, or chewed. This is because breaking the tablet may result in a rapid drug release that could lead to elevated concentrations in the body.

Q: What are the general guidelines for using Syntophyllin in pediatric populations?

Regulatory documents indicate that dosing for children above one year of age is calculated based on factors including body weight and age. Official guidelines define specific maximum limits for the total daily dose.

Q: What are the most commonly reported side effects of Syntophyllin?

According to official regulatory sources, commonly reported side effects include nausea, upset stomach, and headache. Other noted effects are restlessness, irritability, and difficulty falling asleep (insomnia).

Q: Can Syntophyllin affect sleep patterns?

Yes, difficulty falling asleep or staying asleep, known as insomnia, is listed in official documents as a common side effect.

Q: How long does Syntophyllin typically stay in the body?

Official pharmacokinetic data shows that the time the drug stays in the body, or the serum half-life, varies widely between individuals. Factors such as age, smoking status, and coexisting health conditions like liver or heart disease significantly influence how quickly the body clears the medicine.

Q: Is it generally okay to consume alcohol while taking Syntophyllin?

Official regulatory sources note that a single large amount of alcohol has been shown to reduce the body’s ability to clear theophylline (the active component). This effect can potentially lead to an increase in the drug's concentration in the body.

Q: Is Syntophyllin safe for people with liver conditions?

Official prescribing information indicates that liver disease (such as acute hepatitis or cirrhosis) can significantly slow the body's ability to process and clear theophylline. Official labeling notes that use in these patients requires caution and may require dosage modification.

Q: Does Syntophyllin have any known food interactions?

Yes, official documents mention that certain foods and dietary factors may affect absorption. For example, high intake of charbroiled meats, cruciferous vegetables, or tannin-rich foods may interfere with how the body takes in the medicine.

Q: What should people generally know about combining Syntophyllin with herbal supplements?

Official drug interaction warnings advise caution regarding herbal supplements. For example, St. John’s wort is listed as an agent that can interact by altering theophylline blood levels, potentially reducing the medicine's effectiveness.

Q: Is Syntophyllin available in a generic form?

Yes, the active component of Syntophyllin, theophylline, is described in official drug information as being available in generic forms under various non-brand names.

Q: What is the standard procedure if a dose of Syntophyllin is missed?

Regulatory guidance advises that if a dose is missed, it should be taken as soon as possible. However, the official advice emphasizes that individuals should not exceed the total amount prescribed for one single day.

Q: Why do some online discussions mention that Syntophyllin causes dizziness?

Official documentation lists potential side effects related to the central nervous system (CNS), including headache, restlessness, and irritability. Dizziness is categorized as one of the potential CNS excitation side effects that can occur.

Q: Is Syntophyllin approved for use during pregnancy?

Official regulatory bodies classify theophylline under different systems. In the US, it is Pregnancy Category C, meaning animal studies showed some adverse effects but there are no adequate studies in humans. TGA Australia classifies it as Category A, which suggests no proven increase in malformation frequency.

Q: Can people with high blood pressure use Syntophyllin?

Official prescribing information lists high blood pressure (hypertension) as a condition requiring caution when theophylline is used. This means that its use is noted as requiring caution and observation.

Q: Do the reported side effects of Syntophyllin typically lessen after the first few weeks of use?

Clinical data summaries indicate that while some individuals may experience side effects during the first few days of starting treatment, these effects may subsequently decrease or disappear over a short period of time.

Q: Is it common for patients to feel nauseous when starting Syntophyllin?

Yes, official regulatory summaries list upset stomach and nausea as common side effects that can occur when initiating therapy with the drug.

Q: Does Syntophyllin interact with common hormonal birth control methods?

Official drug interaction information notes that estrogen-containing oral contraceptives can reduce the body's ability to clear theophylline. This effect may potentially lead to an increase in the concentration of the drug in the blood.

Q: Are there known contraindications for Syntophyllin besides the main conditions listed?

Yes, official regulatory documents list several contraindications, which are specific conditions where the drug should not be used. These include known hypersensitivity to the drug, active peptic ulcer disease, and a history of seizure disorders.

Q: What official evidence supports the use of Syntophyllin for its stated benefits?

Official regulatory documents state that Syntophyllin (Theophylline) is indicated for the treatment of symptoms associated with reversible bronchospasm. This includes chronic asthma, bronchitis, and emphysema.

Q: What is the typical frequency for which Syntophyllin is prescribed?

Depending on the specific type of tablet or formulation, the drug is commonly prescribed to be taken once or twice every day.

Q: Can older adults experience different side effects from Syntophyllin compared to younger adults?

Yes, official regulatory precautions note that older adults may be more susceptible to adverse effects. This is because their bodies may clear the medicine more slowly, which may lead to higher drug concentrations, which increases the potential for adverse effects.

Q: Is it generally necessary to take Syntophyllin at the exact same time every day?

Regulatory guidance emphasizes taking the medicine at the same time each day. This helps maintain a constant and consistent amount of the drug in the bloodstream, which is important for maintaining optimal therapeutic levels.

Q: Are there any known allergens or inactive ingredients in Syntophyllin?

Official warnings caution patients to inform their healthcare provider if they have an allergy to the medicine itself or any of its components. For the injection form, for example, ethylenediamine is listed as a potential ingredient that may cause an allergic reaction.

Q: Are there any known drug classes that should not be combined with Syntophyllin?

Numerous drugs, including certain antibiotics (like macrolides or quinolones) and oral contraceptives, are known to decrease the clearance of theophylline, which can lead to increased serum concentrations of the drug.

Q: Can older adults experience different side effects from Syntophyllin compared to younger adults?

Older adults may be more susceptible to adverse effects due to a slower clearance of the medicine from the body, which could result in higher drug concentrations and an increased risk of toxicity.

How to Store and Dispose of Syntophyllin?

Regulatory documents mandate specific conditions for the storage and disposal of Syntophyllin (Aminophylline) to ensure product stability and safety.

Storage Requirements

The medicine must be stored at controlled room temperature, generally below 25°C or 30°C, and must be protected from light. It is an explicit instruction that the injection solution should not be frozen.

Syntophyllin must be kept in its original, tightly closed container and, like all medications, out of the sight and reach of children.

Disposal Instructions

Disposal of unused or expired Syntophyllin must be done according to local regulations for pharmaceutical waste. Individuals should utilize a drug take-back program if available. The official instruction is not to flush the medicine down the toilet or dispose of it in household trash unless following the specific mixing procedure for non-hazardous medicines.